The Evaluation of Dupilumab In Chronic Spontaneous Urticaria Treatment

Families reported quality of life improvements when they used peanut oral immunotherapy instead of simply avoiding peanuts.

As many as one quarter of people with chronic urticaria also have metabolic syndrome, data suggest.

Patients reported quality-of-life benefits from treatment for nonsegmental vitiligo, even when clinical improvement started slowly.

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Pediatric dermatology faces access disparities due to lack of awareness, language barriers, and training gaps in recognizing diverse skin conditions.

Identifying specific biomarkers and clinical characteristics is crucial for predicting a patient's response to both existing and emerging treatments for chronic spontaneous urticaria, thereby moving toward a more personalized approach to care.